Eukaryotic and prokaryotic cells in which ribonucleoside kinase activity has been investigated usually contain two enzymatic activities, one specific for adenosine and the other specific for uridine and cytidine. Escherichia coli and Salmonella typhimurium are exceptions to this because they contain guanosine-inosine kinase (ATP:guanosine 5Ј-phosphotransferase [EC 2.7.1.73]) instead of adenosine kinase (24) . Guanosinespecific ribonucleoside kinase activity has been demonstrated with certainty in only a few organisms, including E. coli, S. typhimurium (24) , and Trichomonas vaginalis (20) . It is also found in the mitochondria of plants and mammals (8, 33) . The E. coli enzyme is encoded by the gsk gene, which has been mapped to 11 min on the linkage map (2, 14) .
The utilization of exogenously supplied or endogenously synthesized guanosine and inosine for nucleotide biosynthesis in E. coli and S. typhimurium occurs through two pathways. The major pathway involves phosphorolysis of guanosine or inosine to the corresponding nucleobase and ribose 1-phosphate. This reaction is catalyzed by purine nucleoside phosphorylase, which is encoded in E. coli by the deoD gene. Guanine and hypoxanthine are subsequently phosphoribosylated to their corresponding nucleoside monophosphates by guanine and hypoxanthine phosphoribosyltransferases (gpt and hpt, respectively). The minor pathway involves direct phosphorylation of guanosine or inosine to the corresponding nucleoside 5Ј-monophosphate solely through the action of guanosine kinase. The guanosine-inosine kinase pathway can be studied unambiguously in vivo only in deoD mutant strains where the function of guanosine kinase has been demonstrated to be essential for guanosine salvage (11, 14, 15) .
Methods. The E. coli K-12 strains used in this study are shown in Table 1 . The growth medium was either NZY broth (13) or AB minimal medium (7) supplemented with glucose (0.2%) and thiamine (0.5 mg/liter). When necessary, methionine or histidine was added to 40 mg/liter. Hypoxanthine, adenine, or guanine was added to 15 mg/liter, and guanosine was added to 30 mg/liter. Ampicillin was used at a concentration of 100 mg/liter, and tetracycline was used at 10 mg/liter. The cloning vectors used were pBR322 (6), pUHE23.2 (provided by H. Bujard, University of Heidelberg, Heidelberg, Germany), pBluescriptKS ϩ , and pBluescriptKS Ϫ (Stratagene Cloning Systems). In addition, pKB800 was used to provide a plasmidborne bacteriophage cl857 allele (3). Procedures for transduction by bacteriophage P1 (19) and bacteriophage (31) , as well as transformation with plasmid DNA (18), have been previously described.
Plasmid DNA and bacteriophage DNA were isolated by standard techniques (5, 9) . Restriction endonuclease digestions, removal of cohesive ends of DNA fragments with the large fragment of E. coli DNA polymerase I, dephosphorylation of DNA with calf intestinal alkaline phosphatase, and ligation of DNA fragments with T4 DNA ligase were performed as recommended by the suppliers of the enzymes. Nucleotide sequences were determined by the chain termination method with dideoxyribonucleotides and single-stranded phagemid DNA derived from pBluescriptKS ϩ and pBluescriptKS Ϫ as the templates (28, 29) . Polymerization was achieved with Sequenase T7 DNA polymerase as recommended by the supplier (United States Biochemical Corp.). Sequence ladders were established by electrophoresis of sequencing reactions in buffer gradient gels containing 8 M urea and 6% polyacrylamide followed by autoradiography of the dried gels as previously described (28) .
Guanosine kinase was partially purified from strain HO340 harboring pHA460 by precipitation with ammonium sulfate at 40 to 50% saturation, followed by chromatography on Poros 50 HQ (Perseptive Biosystems) strong anion-exchange medium with elution from 0 to 1 M NaCl over a period of 30 min. These two steps resulted in approximately 40-fold purification. The material was then subjected to electrophoresis as previously described (17) . Four lanes of different amounts of partially purified guanosine kinase were electrophoresed (2 ϫ 4.8 g and 2 ϫ 9.6 g of total protein). Prestained molecular weight markers (Bio-Rad) were loaded on the same gel, and after separation, the region of the gel between the markers corre-sponding to M r s of 50,000 and 35,100 was electroblotted to Immobilon P polyvinylidene difluoride membrane (Millipore) by using a semidry electroblotter and stained as previously described (26) . The band corresponding to guanosine kinase (M r , 43,500) was excised from each lane. A single band was used for automated N-terminal sequence analysis employing an Applied Biosystems 477A Protein Sequencer with on-line phenylthiohydantoin-amino acid analysis and utilizing the blot cartridge. Sequencing protocols were those recommended by the manufacturer. Bands from three lanes were used for amino acid composition analysis (about 3.5 g of protein). The bands were treated with 6 M HCl for 24 h (26), and hydrolysates were analyzed as previously described (4) .
Cloning of the gsk gene. The purE gsk-1 deoD strains HO1070, HO1071, and SØ445 (Table 1) require purines for growth. This requirement can be satisfied by the purine base hypoxanthine or by the combined addition of the purine bases adenine and guanine to the growth medium. In contrast, adenine and guanosine, in the presence of histidine, cannot satisfy the purine requirement because of the strains' lack of guanosine kinase and purine nucleoside phosphorylase activities (15) . In the presence of histidine, the histidine biosynthetic pathway is repressed and the byproduct of this pathway, 5Ј-phosphoribosyl-5-amino-4-imidazole carboxamide, also a precursor in de novo purine biosynthesis, is not available to allow IMP synthesis. As a consequence of this, adenine cannot be converted to IMP. Lack of IMP prohibits the formation of guanine nucleotides through IMP dehydrogenase and GMP synthetase, and guanosine cannot be directly converted to guanine nucleotides because of the lack of guanosine kinase. Thus, the strains lack the means of producing a guanine nucleotide pool under these conditions. Complementation with a functional gsk allele, however, allows guanosine to serve as a guanine nucleotide source in the presence of histidine.
Complementation of gsk-1 by the virulent phages of the Kohara gene bank was achieved as follows. The bacteriophage -sensitive strain HO1071 was transformed with pKB800 DNA. The resulting strain, HO1071/pKB800, was then infected by bacteriophage and the cells were plated at 32ЊC on glucose minimal medium supplemented with adenine and guanosine as the purine sources with histidine present. Complementation of gsk-1 resulted in growth on this medium. The presence of pKB800 served to repress lytic growth of the virulent recombinant phages. Complementation by plasmidborne gsk alleles was achieved by plating transformed gsk cells on medium containing adenine and guanosine as the purine source and with histidine and the required antibiotic present.
To clone the gsk gene, we first compared the proC-purE region at 11 min of the E. coli linkage map (2, 14) with the physical map of Kohara et al. (16) around position 500 kbp. We analyzed bacteriophage clones 8C4(151), 12H5(152), 4B10(153), and 7C12(154) for the presence of the gsk gene by complementation of gsk-1 and found that 12H5(152) and 4B10(153) were able to complement the gsk-1 allele, whereas 8C4(151) and 7C12(154) were not. DNA was isolated from strain 12H5(152), and a 4.9-kbp DNA fragment generated by restriction endonuclease EcoRV and BamHI digestion was ligated to EcoRV-BamHI-digested pBR322 DNA, resulting in the generation of pGSK2, which also complemented gsk-1 (Fig.  1) . The transformants harboring pGSK2 were able to utilize both guanosine and inosine. The BamHI site (right-hand end of the bar showing pGSK2 in Fig. 1 ) was generated fortuitously FIG. 1. Cloning, restriction, and complementation analyses of the gsk gene. The physical map of the 500-to 535-kbp region of the E. coli chromosome is shown at the top. A map of selected restriction endonuclease recognition sites is given, as well as the extent of the DNA fragments harbored in the 12H5(152) and 4B10(153) recombinant phages (redrawn from Kohara et al. [16] ). Below the map of the phages, the 4.9-kbp EcoRV-BamHI(Sau3AI) DNA fragment inserted in pGSK2 is shown. This insert DNA fragment was cloned in the EcoRI and BamHI sites of pBR322. Below pGSK2 are shown the plasmids used for complementation and plasmid-specified polypeptide analyses. In pHA450KS ϩ , the 2.9-kbp SmaI-BamHI DNA fragment of pGSK2 was inserted in the SmaI and BamHI sites of pBluescriptKS ϩ . To construct pHA460, BssHII-digested pHA450KS ϩ DNA was filled in with dCTP and dGTP in the presence of the large fragment of E. coli DNA polymerase I and then digested with BamHI. This DNA was ligated to pUHE23.2 DNA that had been digested with EcoRI, treated with S1 nuclease, and then digested with BamHI. Plasmid pHA450.2KS ϩ contains the 2.2-kbp SmaI-EcoRI DNA fragment of pGSK2 in pBluescriptKS (Fig. 1) . The results of this analysis show that in addition to pGSK2, pHA450KS ϩ and pHA460 complement gsk-1, whereas pHA450.2KS ϩ and pHA452KS ϩ do not. We therefore conclude that the coding sequence of gsk is located to the right of the BssHII site and extends into the region between the EcoRI and BamHI sites.
Nucleotide sequence and transcription of the gsk gene. Determination of the sequence of the gsk gene was performed by using a set of subclones covering the entire PvuI-Sau3AI-(BamHI) DNA fragment. The sequence of both strands with complete overlap of all cloning junctions was determined. The PvuI-Sau3AI DNA fragment (Fig. 2) contains 2,114 bp and revealed an open reading frame which we assigned to the gsk gene on the basis of the complementation analysis described above (Fig. 1 ) and the minicell experiments described below. This open reading frame, which begins at adenylate residue 466 and covers 433 codons, encodes a putative polypeptide with a calculated molecular mass of 48,113 Da. The translation initiation codon of the open reading frame is preceded by a stretch of adenylate residues (SD in Fig. 2 ) with only poor homology to the consensus Shine-Dalgarno sequence (30) .
To determine the transcription initiation point of the gsk gene, a primer extension analysis was performed on RNA templates isolated from strains harboring gsk on a multicopy plasmid, as well as from a haploid strain. The oligonucleotide used to prime reverse transcriptase-mediated polymerization annealed to a template sequence within the coding region of the gsk gene (Fig. 2) . The results shown in Fig. 3 indicate that transcription is initiated at guanylate residue 356. Eight nucleotides upstream of the transcription start site is the hexanucleotide sequence TGTAAG, which we propose as a Ϫ10 region, as it is in reasonable agreement with the consensus Pribnow box TATAAT (27) . From the nucleotide sequence, we were unable to identify a hexanucleotide sequence with proper spacing from the Ϫ10 region that exhibited significant homology to a consensus Ϫ35 region. As expected, the transcript found in the haploid strain showed the same start point as that from the gsk polyploid strain, but the gsk-specified mRNA in the haploid strain was less abundant. Inspection of the nucleotide sequence downstream of the gsk coding region failed to reveal (30) . The asterisks indicate nucleotides 504 to 524, which are complementary to the oligonucleotide used in primer extension analysis of the 5Ј end of the gsk-specified mRNA.
any transcription termination sequences resembling rho-independent terminators. Furthermore, an open reading frame begins at adenylate residue 1,823 and extends out of the sequenced DNA fragment. We do not have experimental evidence of translation of this open reading frame. The gskspecified mRNA also appears to include a 110-nucleotide leader sequence 5Ј to the translation start site shown in Fig. 2 . The direction of transcription of the gsk gene is thus rightward in Fig. 1, i. e., towards higher nucleotide numbers on the physical map, and therefore clockwise on the genetic map.
Polypeptides encoded by gsk-containing plasmids. Expression of the gsk gene was analyzed in minicells. Figure 4 shows the results of an analysis of the polypeptides specified by the gsk-complementing plasmid pHA450KS . gsk-complementing plasmid pHA450 KS ϩ (lane 1) produced a 43,500-M r polypeptide which is absent from the three remaining lanes. This band was also visible in the Coomassie blue-stained gel. The noncomplementing plasmid pHA450.2KS
ϩ produced a polypeptide migrating as a faint band with an M r of 38,600. This polypeptide represents a truncated version of the guanosine kinase subunit. Both pHA450KS ϩ and pHA450.2KS ϩ produced polypeptides that were derived from the upstream sequence and migrated as diffuse bands with M r s of 33,000 to 36,000. We conclude that the polypeptide with an M r of 43,500 represents the guanosine kinase subunit. This value is in rough agreement with the value of 48,113 Da obtained by calculation from the deduced amino acid sequence.
To confirm the reading frame assignment and identification of the 43,500-M r band as the guanosine kinase subunit, Nterminal sequencing and amino acid composition analyses were performed from a blot of a partially purified enzyme preparation. The results of the amino acid composition analysis were within 10% of the values predicted for the amino acid composition derived from the nucleotide sequence (data not shown). The results of N-terminal analysis yielded the amino acid sequence Met-Lys-Phe-Pro-Gly-Lys-Arg-Lys-Ser-Lys with the expected mass yield based on amino acid analysis. This sequence is in perfect agreement with the N-terminal amino acid sequence predicted from the nucleotide sequence of the gsk gene. The presence of the initiating methionine residue in the sequence demonstrates that this residue is not cleaved from the synthesized guanosine kinase; there was no trace of lysine in the first cycle of the sequence.
Overexpression of the gsk gene. The amounts of guanosine and inosine kinase activities specified by some of the plasmids constructed during this work were measured as described before (14, 15) . Strains harboring the plasmids which complement gsk (HO340/pHA450KS ϩ and HO340/pHA460) contain high levels of activities, 250 and 578 nmol/min/mg of protein, respectively. This is 40 to 60 times the approximately 6 to 8 nmol/min/mg of protein found in the haploid strain (HO340/ pBluescriptKS ϩ ). Inosine kinase activities in strains HO340/ pHA450KS ϩ and HO340/pHA460 were 53 and 102 nmol/ min/mg of protein, respectively, compared with less than 2 nmol/min/mg of protein in the haploid strain.
Sequence similarity. The protein sequence databanks were searched for homologous proteins by utilizing both the BLAST (1) and FASTA (25) algorithms. The databases employed were SwissProt (release 28.0), Pir (release 40.0), and GenPept (release 83.0). The BLASTP program was run three times with different percent accepted mutations (PAM) values of 40, 120, and 250 to increase the likelihood of finding significant matches with low identity. The PC-Gene suite (Intelligenetics, Inc.) of sequence analysis programs was used for protein primary sequence analysis. FIG. 3 . Analysis of the gsk-specified mRNA by primer extension. An autoradiogram of a 6% denaturing polyacrylamide gel is shown. Primer extension was performed as previously described (13) . Lanes G, A, T, and C are the sequence ladder. Lane 1 shows extension of the primer on an RNA template isolated from strain HO340/pGSK2 (i.e., a strain multiploid for the gsk gene). Lane 2 shows the extension of the primer on an RNA template isolated from strain HO340 (i.e., a haploid strain). The nucleotide sequence of the template strand is given to the left. The numbers on the left indicate nucleotide positions, and the arrowhead indicates the transcription initiation nucleotide. Two entries exist for proteins with sequences nearly identical to ours. The first of these is identified as inosine-guanosine kinase with an unpublished 1,756-bp entry in the DNA database (22) . Our derived amino acid sequence differs at several residues from this sequence and in the overall length of the polypeptide. The second sequence is a putative 34,600-Da polypeptide derived from the nucleotide sequence of the visA gene region of the E. coli chromosome (21) . This region is very close to gsk on the chromosome, and the relevant nucleotide sequence, which encodes an open reading frame of 312 amino acids, appears to be a truncation of the gsk-specified open reading frame occurring from a frameshift error in the sequence determination. Further inspection of the results of the search revealed some interesting matches. Many of the proteins with known functions identified in the search exhibited similarity to two amino acid sequence regions within guanosine kinase. These two regions corresponded roughly to amino acids 206 to 276 and 330 to 410 in the guanosine kinase sequence. All except one of these proteins shared the property of utilizing mononucleotides. These proteins included IMP dehydrogenase, thymidine kinase, aspartyl and prolyl tRNA synthetases, and ribokinase. The one exception was the ␣-ketoglutarate dehydrogenase E1 component, which also showed homology to guanosine kinase in these regions. The finding of similarity between a number of mononucleotide-utilizing enzymes may suggest a common function for the areas of sequence similarity. One possible function of these two regions could be interaction with the ribose and/or phosphate portion of the mononucleotides. Especially interaction with the phosphate portion might explain why ␣-ketoglutarate dehydrogenase was also found to be similar to guanosine kinase in these regions. The E1 component of this enzyme binds thiamine; the phosphate moiety (or moieties) of the cofactor could interact with amino acids present in the two homologous regions.
Conclusion. We have cloned the gsk gene of E. coli and concluded that this gene is the structural gene for guanosine kinase: the cloned gene restores guanosine and inosine utilization to the gsk-1 mutant strain, and cells harboring a plasmid-borne gsk gene contain elevated levels of guanosine kinase activity. Guanosine and inosine kinase activities were also increased in parallel. This work confirms that phosphorylation of both guanosine and inosine is catalyzed by the same enzyme, as has been previously shown by genetic and physiological studies (14, 15) , and will facilitate the construction of ⌬gsk strains that can be used to clone mutant E. coli gsk alleles, as well as heterologous guanosine kinase encoding genes.
Nucleotide sequence accession number. The nucleotide sequence of the 2,114-bp PvuI-Sau3AI-generated DNA fragment discussed in this report has been submitted to GenBank and assigned accession number L35149.
